{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:58:42Z","timestamp":1775473122793,"version":"3.50.1"},"reference-count":41,"publisher":"Medical Association of Zenica-Doboj","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicinski Glasnik"],"published-print":{"date-parts":[[2020,10,9]]},"abstract":"<jats:p>&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Aim&amp;lt;\/strong&amp;gt; &amp;lt;br \/&amp;gt;Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumours with varying clinical expression and behaviour. Because of indolent behaviour of NENs, reviewing and evaluation of epidemiological characteristics is a challenge. The aim of this study was to assess prevalence of NENs at tertiary hospitals considering age, gender, location, and grade.&amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Methods&amp;lt;\/strong&amp;gt; &amp;lt;br \/&amp;gt;Electronic files were used for a retrospective assessment of the patients with NENs of the gastroenteropancreatic tract and&amp;lt;br \/&amp;gt;bronchopulmonary system in tertiary hospitals in Bosnia and Herzegovina over the past 15 years (2005-2020).&amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Results&amp;lt;\/strong&amp;gt;&amp;lt;br \/&amp;gt;Among 438 patients, 291(66.4%) were males and 147 (33.6%) females; the median age was 62 years. The lungs were&amp;lt;br \/&amp;gt;the most frequent site, 304 (69.4%), followed by the pancreas, 22 (5.0%), colon, 14 (3.2%), stomach, 13 (2.9%), appendix,&amp;lt;br \/&amp;gt;13 (2.9%), rectum,11 (2.5%), small intestine, eight (1.8%) and gallbladder, one (0.2%). Metastases were most frequently found in the liver, 35 (8%) and lymph nodes, 15 (3.42%).&amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Conclusion&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; The results were largely consistent with those in literature, including age, gender, location, and the degree of differentiation. Most metastases originated from high-grade tumours and greater impairment of the liver.&amp;lt;\/p&amp;gt;<\/jats:p>","DOI":"10.17392\/1219-21","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T10:28:16Z","timestamp":1713695296000},"page":"77-83","source":"Crossref","is-referenced-by-count":0,"title":["An epidemiological study of neuroendocrine tumours at tertiary hospitals in Bosnia and Herzegovina"],"prefix":"10.17392","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-6980","authenticated-orcid":false,"given":"Maja","family":"Konrad \u010custovi\u0107","sequence":"first","affiliation":[{"name":"University Clinical Centre of Tuzla","place":["Tuzla,Bosnia and Herzegovina"],"department":["Pathology Department, Polyclinic for Laboratory Diagnostics"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermina","family":"Iljazovi\u0107","sequence":"additional","affiliation":[{"name":"University Clinical Centre of Tuzla","place":["Tuzla,Bosnia and Herzegovina"],"department":["Pathology Department, Polyclinic for Laboratory Diagnostics"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Sadikovi\u0107","sequence":"additional","affiliation":[{"name":"University Clinical Centre of Tuzla","place":["Tuzla,Bosnia and Herzegovina"],"department":["Pathology Department, Polyclinic for Laboratory Diagnostics"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zinaida","family":"Karasalihovi\u0107","sequence":"additional","affiliation":[{"name":"University Clinical Centre of Tuzla","place":["Tuzla,Bosnia and Herzegovina"],"department":["Pathology Department, Polyclinic for Laboratory Diagnostics"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"49509","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"ref1","article-title":"WHO Classification of tumors of the digestive system. 4\u036d \u036a Ed","author":"FBosmanF","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND. \nIn: WHO Classification of tumors of the digestive \nsystem. 4\u036d \u036a Ed. Geneva: World Health Organization, \n2010."},{"key":"ref2","first-page":"172","article-title":"Vienna Consensus Conference participants","author":"MPavelM","year":"2016","unstructured":"Pavel M, O'Toole D, Costa F, Capdevila J, Gross D, \nKianmanesh R, Krenning E, Knigge U, Salazar R, \nPape UF, \u00d6berg K, Vienna Consensus Conference \nparticipants. ENETS Consensus Guidelines Update \nfor the management of distant metastatic disease of \nintestinal, pancreatic, bronchial neuroendocrine ne-\noplasms (NEN) and NEN of unknown primary site. \nNeuroendocrinology 2016; 103:172-85.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"ref3","first-page":"6","article-title":"Surgical treatment of liver metastases in patient with neuroendocrine tumors","author":"ASaeedA","year":"2013","unstructured":"Saeed A, Buell JF, Kandil E. Surgical treatment of \nliver metastases in patient with neuroendocrine tu-\nmors. Ann Trans Med 2013; 1(suppl 1):6.","journal-title":"Ann Trans Med"},{"key":"ref4","first-page":"442","article-title":"Surgical approaches for liver metastases in carcinoid tumors","author":"EKandilE","year":"2015","unstructured":"Kandil E, Saeed A, Buell J. Surgical approaches for \nliver metastases in carcinoid tumors. Gland Surg \n2015; 4(suppl 5):442-6.","journal-title":"Gland Surg"},{"issue":"2","key":"ref5","first-page":"371","article-title":"Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms","author":"JHoflandJ","year":"2020","unstructured":"Hofland J, Kaltsas G, de HerderWW. Advances in \nthe diagnosis and management of well-differentia-\nted neuroendocrine neoplasms. Endocr Rev 2020; \n41(suppl 2):371-403.","journal-title":"Endocr Rev"},{"key":"ref6","article-title":"Pathology &Genetics: Tumors of the Lung, Pleura, Thymus and Heart","author":"WTravisW","year":"2014","unstructured":"Travis WD, Brambilla E, Muller-Hermelink HK, \nHarris CC. Pathology &Genetics: Tumors of the \nLung, Pleura, Thymus and Heart. Lyon: IARC Pre-\nss, 2014."},{"key":"ref7","article-title":"World Health Organization classification of Tumours. Pathology and Genetics of Endocrine Organs","author":"PslKleihuesPsl","year":"2004","unstructured":"Kleihues PSL. World Health Organization classifi-\ncation of Tumours. Pathology and Genetics of En-\ndocrine Organs. Lyon: IARC Press, 2004."},{"issue":"4","key":"ref8","first-page":"934","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","author":"IModlinI","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis \nof 13,715 carcinoid tumors. Cancer 2003; 97(suppl \n4):934-59.","journal-title":"Cancer"},{"issue":"10","key":"ref9","first-page":"2655","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","author":"OHausoO","year":"2008","unstructured":"Hauso O, Gustafsson BI, Kidd M, Waldum HL, \nDrozdov I, Chan AK, Modlin IM. Neuroendocrine \ntumor epidemiology: contrasting Norway and North \nAmerica. Cancer 2008; 113(suppl 10):2655-64.","journal-title":"Cancer"},{"issue":"1","key":"ref10","first-page":"1","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","author":"BLawrenceB","year":"2011","unstructured":"Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd \nM, Modlin IM. The epidemiology of gastroentero-\npancreatic neuroendocrine tumors. Endocrinol Me-\ntab Clin North Am 2011; 40(suppl 1):1-18.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"ref11","first-page":"2563","article-title":"Carcinoid tumors of the gastrointestinal tract: trend in incidence in England since 1971","author":"LEllisL","year":"2010","unstructured":"Ellis L, Shale MJ, Coleman MP. Carcinoid tumors \nof the gastrointestinal tract: trend in incidence in \nEngland since 1971. Am J Gastroenterol 2010; \n105(suppl 12):2563-9.","journal-title":"Am J Gastroenterol"},{"key":"ref12","first-page":"68","article-title":"Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis","author":"ELeonciniE","year":"2016","unstructured":"Leoncini E, Carioli G, La Vecchia C, Boccia S, Rin-\ndi G. Risk factors for neuroendocrine neoplasms: \na systematic review and meta-analysis. An Oncol \n2016; 27:68-81.","journal-title":"An Oncol"},{"key":"ref13","first-page":"368","article-title":"Increased incidence trend of lowgrade and high-grade neuroendocrine neoplasms","author":"ELeonciniE","year":"2017","unstructured":"Leoncini E, Boffetta P, Shafir M, Aleksovska K, \nBoccia S, Rindi G. Increased incidence trend of low-\ngrade and high-grade neuroendocrine neoplasms. \nEndocrine 2017; 58:368-79.","journal-title":"Endocrine"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s00464-005-0232-4","article-title":"Gastric carcionoids: a temporal increase with proton pump introduction","author":"NHodgsonN","year":"2005","unstructured":"Hodgson N, Koniaris LG, Livingstone AS, Frances-\nchi D. Gastric carcionoids: a temporal increase with \nproton pump introduction. Surg Endoscop 2005; \n19(suppl 12):1610-2.","journal-title":"Surg Endoscop"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/ijms21020662","article-title":"Proton Pump Inhibitor Use, hypergastrinemia, and gastric carcinoids-what is the relationship?","author":"MMccarthyM","year":"2020","unstructured":"McCarthy MD. Proton Pump Inhibitor Use, hyper-\ngastrinemia, and gastric carcinoids-what is the rela-\ntionship? Int J Mol Sci 2020; 21(suppl 2):662.","journal-title":"Int J Mol Sci"},{"key":"ref16","first-page":"1770","article-title":"A common classification framework for neuroendocrine neoplasms: International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","author":"GRindiG","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-ArdekaniB,Asa SL, \nBosman FT, Brambilla E, Busam KJ, de Krijger \nRR, Dietel M, El-NaggarAK,Fernandez-Cuesta L, \nKl\u00f6ppel G, McCluggage WG, Moch H, Ohgaki H, \nRakha EA, ReedNS,RousBA,SasanoH,Scarpa A, \nScoazec JY, Travis WD, TalliniG,Trouillas J, van \nKrieken JH, Cree IA. A common classification \nframework for neuroendocrine neoplasms: Interna-\ntional Agency for Research on Cancer (IARC) and \nWorld Health Organization (WHO) expert consen-\nsus proposal. Mod Pathol 2018; 31:1770-86.","journal-title":"Mod Pathol"},{"issue":"1","key":"ref17","first-page":"5","article-title":"What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for pancreatic neuroendocrine neoplasms?","author":"JChoeJ","year":"2019","unstructured":"Choe J, Kim KW, Kim HJ, Kim DW, Kim KP, Hong \nSM, Ryu JS, Tirumani SH, Krajewski K, Ramaiya \nN. What Is New in the 2017 World Health Organi-\nzation Classification and 8th American Joint Com-\nmittee on Cancer Staging System for pancreatic \nneuroendocrine neoplasms? Korean J Radiol 2019; \n20(suppl 1):5-17.","journal-title":"Korean J Radiol"},{"key":"ref18","first-page":"153","article-title":"Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","author":"MFraenkelM","year":"2014","unstructured":"Fraenkel M, Kim M, Faggiano A, de Herder WW, \nValk GD. Incidence of gastroenteropancreatic neu-\nroendocrine tumours: a systematic review of the lite-\nrature. Endoc Relat Cancer 2014; 21:153-63.","journal-title":"Endoc Relat Cancer"},{"issue":"8","key":"ref19","first-page":"1975","article-title":"Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry","author":"CKorseC","year":"2013","unstructured":"Korse CM, Taal BG, van Velthuysen ML, Visser O. \nIncidence and survival of neuroendocrine tumours \nin the Netherlands according to histological grade: \nexperience of two decades of cancer registry. Eur J \nCancer 2013; 49(suppl 8):1975-83.","journal-title":"Eur J Cancer"},{"key":"ref20","first-page":"226","article-title":"Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria","author":"OSandvikO","year":"2016","unstructured":"Sandvik OM, S\u00f8reide K, Gudlaugsson E, Kval\u00f8y \nJT, S\u00f8reide JA. Epidemiology and classification \nof gastroenteropancreatic neuroendocrine neopla-\nsms using current coding criteria. Br J Surg 2016; \n103:226-32.","journal-title":"Br J Surg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000151562","article-title":"Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France","author":"CLombard-BohasC","year":"2009","unstructured":"Lombard-Bohas C, Mitry E, O'Toole D, Louvet C, \nPillon D, Cadiot G, Borson-Chazot F, Aparicio T, \nDucreux M, Lecomte T. Thirteen-month registrati-\non of patients with gastroenteropancreatic endocri-\nne tumours in France. Neuroendocrinology 2009; \n89:217-22.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"ref22","first-page":"258","article-title":"Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of China","author":"XJiaoX","year":"2015","unstructured":"Jiao X, Li Y, Wang H, Liu S, Zhang D, ZhouY. Cli-\nnicopathological features and survival analysis of \ngastroenteropancreatic neuroendocrine neoplasms: a \nretrospective study in a single center of China. Chin \nJ Cancer Res 2015; 27(suppl 3):258-66.","journal-title":"Chin J Cancer Res"},{"issue":"3","key":"ref23","first-page":"276","article-title":"Neuroendocrine tumours of the GI tract--data from the German NET Registry","author":"MaasbergsBegumnMaasbergs","year":"2014","unstructured":"BegumN, MaasbergS,Pl\u00f6ckingerU, AnlaufM, Rin-\nkeA, P\u00f6pperlG, Lehnert H, IzbickiJR, Krausch \nM, VashistYK, Raffel A, B\u00fcrk CG, Hoffmann J, Go-\nretzki P, Pape UF. Neuroendocrine tumours of the \nGI tract--data from the German NET Registry. Zen-\ntralbl Chir 2014; 139(suppl 3):276-83.","journal-title":"Zentralbl Chir"},{"issue":"1","key":"ref24","first-page":"61","article-title":"Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors","author":"AstudilloGalv\u00e1njaAstudillo","year":"2013","unstructured":"Galv\u00e1nJA, Astudillo A, Vallina A, Fonse-\nca PJ, G\u00f3mez-Izquierdo L, Garc\u00eda-Carbonero \nR, Gonz\u00e1lez MV. Epithelial-mesenchymal transition \nmarkers in the differential diagnosis of gastroentero-\npancreatic neuroendocrine tumors. Am J Clin Pathol \n2013; 140(suppl 1):61-72.","journal-title":"Am J Clin Pathol"},{"key":"ref25","first-page":"3063","article-title":"One hundred years after \"carcinoid\": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","author":"JYaoJ","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, \nMares JE, Abdalla EK, Fleming JB, Vauthey J, Ras-\nhid A, Evans DB. One hundred years after \"carci-\nnoid\": Epidemiology of and prognostic factors for \nneuroendocrine tumors in 35,825 cases in the United \nStates. J Clin Oncol 2008; 26:3063-72.","journal-title":"J Clin Oncol"},{"issue":"7","key":"ref26","first-page":"1464","article-title":"A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: The rapid pace of no progress","author":"IModlinI","year":"2007","unstructured":"Modlin IM, Champaneria MC, Chan AK, Kidd M. A \nthree-decade analysis of 3,911 small intestinal neu-\nroendocrine tumors: The rapid pace of no progress. \nAm J Gastroenterol 2007; 102(suppl 7):1464-73.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"ref27","first-page":"691","article-title":"Epidemiology of gastroenteropancreatic neuroendocrine tumors","author":"MFraenkelM","year":"2012","unstructured":"Fraenkel M, Kim MK, Faggiano A, Valk GD. Epi-\ndemiology of gastroenteropancreatic neuroendocri-\nne tumors. Best Pract Res Clin Gastroenterol 2012; \n26(suppl 6):691-703.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref28","author":"AChauhanA","unstructured":"Chauhan A, \nYu \nQ, RayN,FarooquiZ,Huang"},{"key":"ref29","first-page":"19245","article-title":"Global burden of neuroendocrine tumors and changing incidence in Kentucky","author":"BB","year":"2018","unstructured":"B, DurbinEB,TuckerT,Evers M, Arnold S, Anthony \nLB. Global burden of neuroendocrine tumors and \nchanging incidence in Kentucky. Oncotarget 2018; \n9(suppl 27):19245-54.","journal-title":"Oncotarget"},{"key":"ref30","first-page":"257","article-title":"Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine","author":"WTravisW","year":"2014","unstructured":"Travis WD. Pathology and diagnosis of neuroen-\ndocrine tumors: lung neuroendocrine. Thorac Surg \nClin 2014; 24:257-66.","journal-title":"Thorac Surg Clin"},{"key":"ref31","first-page":"7","article-title":"Cancer statistics","author":"RSiegelR","year":"2018. 2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer stati-\nstics,2018. CA Cancer J Clin 2018; 68:7-30.","journal-title":"CA Cancer J Clin"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000242109","article-title":"The German NET-Registry: An audit on the diagnosis and therapy of neuroendocrine tumors","author":"UPloeckingerU","year":"2009","unstructured":"Ploeckinger U, Kloeppel G, Wiedenmann B, Loh-\nmann R. The German NET-Registry: An audit on \nthe diagnosis and therapy of neuroendocrine tumors. \nNeuroendocrinology 2009; 90:349-63.","journal-title":"Neuroendocrinology"},{"key":"ref33","first-page":"817","article-title":"Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large perspective and retrospective Italian epidemiological study: the NET management study","author":"AFaggianoA","year":"2012","unstructured":"Faggiano A, Ferolla P, Grimaldi F, Campana D, \nManzoni M, Davi M, Bianchi A, Valcavi R, Papi-\nni E, Giuffrida D. Natural history of gastro-ente-\nro-pancreatic and thoracic neuroendocrine tumors. \nData from a large perspective and retrospective Ita-\nlian epidemiological study: the NET management \nstudy. J Endocrinol Invest 2012; 35:817.","journal-title":"J Endocrinol Invest"},{"key":"ref34","first-page":"2679","article-title":"Digestive neuroendocrine tumor distribution and characteristics according to the 2010 WHO Classification: a single institution experience in Lebanon","author":"HKourieH","year":"2016","unstructured":"Kourie HR, Ghorra C, Rassy M, Kesserouani C, \nKattan J. Digestive neuroendocrine tumor distribution \nand characteristics according to the 2010 WHO Cla-\nssification: a single institution experience in Lebanon. \nAsian Pac J Cancer Prev 2016; 17:2679-81.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreaticneuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)","author":"RGarcia-CarboneroR","year":"2010","unstructured":"Garcia-Carbonero R, Capdevila J, Crespo-Herre-\nro G, Diaz-Perez J, Mart\u00ednez Del Prado M, Alonso \nOrduna V, Sevilla-Garcia I, Villabona-Artero C, \nBeguiristain-G\u00f3mez A, Llanos-Munoz M. Inci-\ndence, patterns of care and prognostic factors for \noutcome of gastroenteropancreaticneuroendocrine \ntumors (GEP-NETs): results from the National Can-\ncer Registry of Spain (RGETNE). Ann Oncol 2010; \n21:1794-803.","journal-title":"Ann Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"15687","DOI":"10.1200\/JCO.2017.35.15_suppl.e15687","article-title":"Clinical and epidemiological features in 495 gastroenteropancreatic neuroendocrine patients in Mexico","author":"RMedrano-GuzmanR","year":"2017","unstructured":"Medrano-Guzman R. Clinical and epidemiologi-\ncal features in 495 gastroenteropancreatic neuro-\nendocrine patients in Mexico. J Clin Oncol 2017; \n35:e15687.","journal-title":"J Clin Oncol"},{"key":"ref37","first-page":"2679","article-title":"The epidemiology of metastases in neuroendocrine tumors","author":"MRiihim\u00e4kiM","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist K, Sundqu-\nist J, Hemminki K. The epidemiology of metasta-\nses in neuroendocrine tumors. Int J Cancer 2016; \n139:2679-86.","journal-title":"Int J Cancer"},{"issue":"7","key":"ref38","first-page":"644","article-title":"Gastric carcinoids after long-term use a proton pump inhibitor","author":"CJianuC","year":"2012","unstructured":"Jianu CS, Fossmark R, Viset T, Qvigstad G, Sordal \nO, M\u00e5rvik R, Waldum HL. Gastric carcinoids af-\nter long-term use a proton pump inhibitor. Aliment \nPharmacol Ther 2012; 36(suppl 7):644-9.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"ref39","first-page":"601","article-title":"Alexandrou A, Blazer DG 3 rd , Felekouras E. Neuroendocrine neoplasms of the appendix: a review of the literature","author":"DMorisD","year":"2018","unstructured":"Moris D, Tsilimigras DI, VagiosS, Ntanasis-Statho-\npoulos I, Karachaliou GS, Papalampros A, Alexan-\ndrou A, Blazer DG 3 rd , Felekouras E. Neuroen-\ndocrine neoplasms of the appendix: a review of the \nliterature. Anticancer Res 2018; 38(suppl 2):601-11.","journal-title":"Anticancer Res"},{"issue":"3","key":"ref40","first-page":"284","article-title":"Epidemiological features of gastroenteropancreatic tumors in Chengdu city with a population of 14 milion based on date from a single institution","author":"LGuoL","year":"2016","unstructured":"Guo LJ, Wang CH, Tang CW. Epidemiological fea-\ntures of gastroenteropancreatic tumors in Chengdu \ncity with a population of 14 milion based on date \nfrom a single institution. Asian Pac J Clin Oncol \n2016; 12(suppl 3):284-8.","journal-title":"Asian Pac J Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0b013e31817f1816","article-title":"Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix","author":"Tanglh","year":"2008","unstructured":"TangLH, ShiaJ, SoslowRA, DhallD, WongWD, \nO'ReillyE, QinJ, PatyP, WeiserMR, GuillemJ, Tem-\npleL, SobinLH, KlimstraDS.Pathologic classificati-\non and clinical behavior of the spectrum of goblet \ncell carcinoid tumors of the appendix. Am J Surg \nPathol 2008; 32:1429-43.","journal-title":"Am J Surg Pathol"}],"container-title":["Medicinski Glasnik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medicinskiglasnik.ba\/article\/18\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicinskiglasnik.ba\/article\/18\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:45:03Z","timestamp":1775468703000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicinskiglasnik.ba\/article\/id\/418\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,10,9]]},"published-print":{"date-parts":[[2020,10,9]]}},"URL":"https:\/\/doi.org\/10.17392\/1219-21","archive":["Internet Archive"],"relation":{},"ISSN":["1840-0132","1840-0132"],"issn-type":[{"value":"1840-0132","type":"electronic"},{"value":"1840-0132","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}